IP Library Granted Patent US 11,193,166
Granted Patent B2
US 11,193,166 · App. 16/164,417 · Granted Dec 7, 2021

Simultaneous background reduction and complex stabilization in binding assay workflows

Inventors: Keunho Ahn (San Diego, CA); Joseph Rokicki (San Diego, CA); Brittany Ann Rohrman (San Diego, CA); Corey M. Dambacher (La Jolla, CA)
Assignee: OMNIOME, INC.
C12Q1/6853C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,193,166
App. No.
16/164,417
Granted
Dec 7, 2021
Kind
B2
Abstract

Method and apparatus to facilitate separation of solution-phase components surrounding an immobilized multicomponent complex while stabilizing association of the components within the complex. The technique can be used for reducing background signal arising from the presence of non-complexed components harboring detectable labels, thereby enhancing signal-to-background ratios and allowing enhanced detection of the multicomponent complex.

Claims (32)

1. A method of identifying a cognate nucleotide, said method comprising the steps of:

(a) contacting an immobilized primed template nucleic acid molecule with a first polymerase and a first test nucleotide to form, without incorporation, an immobilized ternary complex,

wherein the immobilized ternary complex comprises the immobilized primed template nucleic acid molecule and the first polymerase in reversible association with the first test nucleotide;

(b) contacting the immobilized ternary complex with a stabilizing fluid,

wherein the first test nucleotide is substantially insoluble in the stabilizing fluid;

(c) detecting the immobilized ternary complex in contact with the stabilizing fluid; and

(d) identifying the cognate nucleotide from the result of step (c).

2. The method of claim 1 , wherein the first test nucleotide comprises a detectable label and wherein step (c) comprises detecting the immobilized ternary complex in contact with the stabilizing fluid by detecting the detectable label.

3. The method of claim 2 , wherein the detectable label comprises a fluorescent moiety.

4. The method of claim 2 , wherein the first test nucleotide comprises the detectable label, and the first polymerase does not comprise any chemical moiety in energy transfer relationship with the detectable label of the first test nucleotide.

5. The method of claim 1 , wherein step (a) further comprises contacting the immobilized primed template nucleic acid molecule with a second test nucleotide different from the first test nucleotide.

6. The method of claim 1 , further comprising, after step (c), a step of destabilizing the immobilized ternary complex by replacing the stabilizing fluid with a wash solution that removes the first polymerase and the first test nucleotide from contact with the immobilized primed template nucleic acid molecule.

7. The method of claim 6 , further comprising, after the destabilizing step, a step of incorporating a cognate nucleotide into the primer strand of the immobilized primed template nucleic acid molecule.

8. The method of claim 7 , wherein the cognate nucleotide incorporated into the primer strand of the immobilized primed template nucleic acid molecule is a reversible terminator nucleotide comprising a reversible terminator moiety.

9. The method of claim 1 , wherein the immobilized primed template nucleic acid molecule of step (a) is a blocked primed template nucleic acid molecule comprising a reversible terminator moiety.

10. The method of claim 6 , wherein the immobilized primed template nucleic acid molecule of step (a) is a blocked primed template nucleic acid molecule comprising a reversible terminator moiety, and wherein after the destabilizing step there are the further steps of:

cleaving the reversible terminator moiety from the blocked primed template nucleic acid molecule to result in a de-blocked primed template nucleic acid molecule; and

incorporating a cognate nucleotide into the de-blocked primed template nucleic acid molecule.

11. The method of claim 10 , wherein the cognate nucleotide incorporated into the de-blocked primed template nucleic acid molecule is a reversible terminator nucleotide.

12. The method of claim 11 , further comprising repeating all of the steps to determine the identities of consecutive nucleotides in the immobilized primed template nucleic acid molecule.

13. The method of claim 1 , wherein the immobilized primed template nucleic acid molecule is contained within a flow cell.

14. The method of claim 1 , wherein the immobilized primed template nucleic acid molecule is immobilized to the surface of a bead.

15. The method of claim 1 , wherein the stabilizing fluid is a non-aqueous fluid.

16. The method of claim 15 , wherein the non-aqueous fluid is selected from the group consisting of a gas and an oil.

17. The method of claim 1 , wherein step (b) occurs for a duration of at least 10 seconds and at most 10 minutes prior to step (c).

18. The method of claim 1 , wherein the first polymerase comprises a detectable label and wherein step (c) comprises detecting the immobilized ternary complex in contact with the stabilizing fluid by detecting the detectable label of the first polymerase.

19. The method of claim 18 , wherein the detectable label comprises an exogenous fluorescent label attached to the first polymerase.

20. The method of claim 1 ,

wherein the immobilized primed template nucleic acid molecule is contained within a flow cell,

wherein step (a) comprises flowing into the flow cell a first reagent solution that comprises the first polymerase and the first test nucleotide, and

wherein step (b) comprises flowing the stabilizing fluid into the flow cell to replace any of the first reagent solution contained therein.

21. The method of claim 20 , wherein the first reagent solution further comprises a second test nucleotide different from the first test nucleotide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 059278/0153 →
MERGER Recorded Feb 2, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058952/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: AHN, KEUNHO; ROKICKI, JOSEPH; ROHRMAN, BRITTANY A.; DAMBACHER, COREY M.
To: OMNIOME, INC.
Reel/Frame 048505/0432 →
Continuity (2)
Provisional Application 62574308 · Oct 19, 2017
Related Publication 20190119740A1 · Apr 25, 2019